If your pile hasn’t reached this proportion don’t worry. Just keep reading. 😃

Accuracy of Smartwatches in the Detection of Atrial Fibrillation: A Systematic Review and Diagnostic Meta-Analysis @ihtanboga @scaganefe @taylanakgun @drmcap_mc @drselimtopcu @AslanMir28 https://t.co/W60lbh4yfP

🏛️ A 200-Year Journey Through Coronary Disease and Myocardial Infarction 💥 From bloodletting to genomics — the story of humanity’s fight against the #1 killer. 📜 🔹 Origins (1700s–1900s): 🩺 Heberden (1772) → first clinical description of angina. 🧠 Pathologists later linked

#TCT2025 in San Francisco; DIFOCCULT-3 trial just presented by @AslangerE . 6000 ACS patients,18 centers from #Turkiye. Very nice discussions. It is time to paradigm shift from STEMI/NSTEMI to OMI/NOMI myocardial infarction. Proud to be lead discussant of this session. #tsc #acs

Lifetime Benefits of Comprehensive Medical Therapy in Heart Failure with Mildly Reduced or Preserved Ejection Fraction https://t.co/Z8iiwwAFEr

Leaflet durability remains a major challenge for transcatheter heart valves. Bench studies suggest balloon-expandable TAVI valves often show pinwheeling, linked to reduced durability. The DurAVR system (Anteris Technologies) uses a short-frame, biomimetic leaflet design to

We just published the Great debate: fire-and-forget beats personalized lipid-lowering treatment https://t.co/3enK5cA1Li @ProfKausikRay @EugeniaGianos @TKDsosyal @DrMarthaGulati @society_eas @MeralKayikcoglu

Creative Minds, Younger Brains: Engaging in music, dance, painting, or even (some) gaming is linked to delayed brain aging. Article: https://t.co/rexsAc43H4. 🧵1/5 Biophysical modeling, graph theory, and Neurosynth analyses reveal plasticity-driven efficiency in regions most

Honored to see our work featured by #EHJPharmacotherapy in ESC 2025 simpub. Grateful to mentors @CMichaelGibson and James L. Januzzi for their support and guidance, and many thanks to co-authors @ihtanboga and @canyucelkarabay #ESC2025

ENVAD-HF, a prospective RCT in stable HM3 #LVAD recipients, shows angiotensin–neprilysin inhibition is safe and well-tolerated, paving the way for trials of #HF therapies in this population. https://t.co/NrayztGHvi #JACCHF #ESCCongress #WCCardio @MajaCikes @scottdsolomon

Presented at #ESCCongress: In patients with an acute coronary syndrome, stopping aspirin early after PCI and using P2Y12 inhibitor monotherapy was not noninferior to dual therapy with respect to risk of death or ischemic events but did reduce bleeding events. Full NEO-MINDSET

A new treatment, an aldosterone synthase inhibitor, for uncontrolled or resistant hypertension, Phase 3 trial @NEJM #ESC2025 today https://t.co/5XkSfnYZKU

Great debate: artificial intelligence will replace much of what cardiologists do #ESCCongress #digitalhealth @dikadernegi https://t.co/ey2es9nnrp

Presented at #ESCCongress: In older adults with impaired physical performance after MI, multidomain rehabilitation reduced cardiovascular death or unplanned hospitalization at 1 year, with no serious adverse effects. Full PIpELINe trial results: https://t.co/zHTQr6wv9y

Presented at #ESCCongress: In patients with nonobstructive HCM, mavacamten did not significantly improve peak oxygen uptake or decrease symptoms as compared with placebo, and more patients had a reduction in LVEF with mavacamten. Full ODYSSEY-HCM phase 3 trial results:

Presented at #ESCCongress: In patients with cardiovascular disease and an implantable cardioverter–defibrillator, increasing potassium levels to the high-normal range reduced the risk of arrhythmia events, hospitalizations, and death. Full POTCAST trial results:

Presented at #ESCCongress: In patients with heart failure and reduced ejection fraction who were receiving guideline-directed medical therapy, digitoxin lowered the risk of death or hospitalization for heart failure as compared with placebo. Full DIGIT-HF phase 4 trial results:

https://t.co/b4IzoFXvVz @dikadernegi

An amazing review as always by @Richard_D_Riley, @GSCollins ! I also learned it from @f2harrell and have been using restricted cubic splines as a default in continuous variable modeling for many years. https://t.co/D26hztkts8

Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide @dikadernegi @ihtanboga https://t.co/b3up74NrYt

Great debate: artificial intelligence will replace much of what cardiologists do #digitalhealth #artificalintelligence https://t.co/ey2es9mPBR